GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report)’s share price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.00 and traded as high as $0.0007. GB Sciences shares last traded at $0.0007, with a volume of 297,050 shares changing hands.
GB Sciences Stock Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Read More
- Five stocks we like better than GB Sciences
- Consumer Staples Stocks, Explained
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- How to Invest in Insurance Companies: A Guide
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- 3 Small Caps With Big Return Potential
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
